Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The distal portion of chromosome 1p is one of the most commonly affected regions in human cancer. In this study of hereditary and sporadic colorectal cancer, a region of frequent deletion was identified at 32.2 centimorgans from 1ptel. Deletion breakpoints clustered in the vicinity of or inside the gene RIZ , which encodes a retinoblastoma protein-interacting zinc finger protein. Sequence analysis revealed frequent frameshift mutations of the RIZ gene. The mutations consisted of 1- or 2-bp deletions of a coding (A) 8 or (A) 9 tract and were confined to microsatellite-unstable colorectal tumors, being present in 9 of 24 (37.5%) primary tumors and in 6 of 11 (54.5%) cell lines; in 2 cell lines the mutation was homozygous/hemizygous. The mutations apparently were selected clonally in tumorigenesis, because similar poly(A) tracts in other genes were not affected. Two alternative products of the gene exist, RIZ1, which contains a PR ( P RDI-BF1- R IZ1) domain implicated in tumor suppressor function, and RIZ2, which is lacking this motif. Furthermore, the C-terminal region, which contains the poly(A) tracts, includes a PR-binding motif, possibly mediating interactions with other proteins or with RIZ itself (oligomerization). Four of eleven microsatellite-unstable colorectal cancer cell lines, three of which had frameshifts, showed reduced or absent mRNA expression of RIZ1. In a cell line that is homozygous/hemizygous for the typical frameshift mutation, immunoblotting showed truncated RIZ protein, whereas adenovirus-mediated RIZ1 expression caused G 2 /M arrest and apoptosis. We propose that RIZ is a target of the observed 1p alterations, with impairment of the PR domain-mediated function through either frameshift mutation or genomic deletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Cited by
Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
Self-citationDeficient DNA mismatch repair: a common etiologic factor for colon cancer
Peltomaki, P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.735 · Cited by 505
Self-citationLund, A. H., & van Lohuizen, M. (2004) · Genes & Development · doi:10.1101/gad.1232504 · Cited by 489
“1996; Huang 2002), and RIZ has been found to be inactivated by mutations or DNA methylation in a wide variety of human tumors including breast cancer, liver cancer, colorectal cancer, lung cancer, lymphomas, and melanomas (Chadwick et al. 2000; Du et al. 2001; Poetsch et al. 2002; Sasaki et al. 2002; Oshimo et al. 200…”
BackgroundHighly penetrant hereditary cancer syndromes
Nagy, R., Sweet, K., & Eng, C. (2004) · Oncogene · doi:10.1038/sj.onc.1207714 · Cited by 380
Nimer, S. D. (2008) · Blood · doi:10.1182/blood-2007-08-078139 · Cited by 336
Histone methyltransferases in cancer
Albert, M., & Helin, K. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.10.007 · Cited by 306
Steele-Perkins, G., Fang, W., Yang, X.-H., Van Gele, M., Carling, T., Gu, J., Buyse, I. M., Fletcher, J. A., Liu, J., Bronson, R., et al. (2001) · Genes & Development · doi:10.1101/gad.870101 · Cited by 208
PRDM proteins: important players in differentiation and disease
Fog, C. K., Galli, G. G., & Lund, A. H. (2012) · BioEssays · doi:10.1002/bies.201100107 · Cited by 201
“Loss of functional PRDM2 has also been found in many types of solid tumors and in line with a tumor suppressive function, forced PRDM2 expression causes apoptosis and/or cell cycle arrest in cancer cell lines and suppresses growth in vivo [86, 87].”
BackgroundMicroarray Analysis of Butyrate Regulated Genes in Colonic Epithelial Cells
Daly, K., & Shirazi-Beechey, S. P. (2006) · DNA and Cell Biology · doi:10.1089/dna.2006.25.49 · Cited by 174
Woerner, S. M., Benner, A., Sutter, C., Schiller, M., Yuan, Y. P., Keller, G., Bork, P., Doeberitz, M. V. K., & Gebert, J. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206421 · Cited by 165
“For some of these mutated gene products, functional support for promoting tumor cell growth has been provided (Souza et al., 1999; Chadwick et al., 2000; Liu et al., 2000; Piao et al., 2000; Sakurada et al., 2001).”
BackgroundHistone modifications as a pathogenic mechanism of colorectal tumorigenesis
Gargalionis, A. N., Piperi, C., Adamopoulos, C., & Papavassiliou, A. G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.002 · Cited by 53
The Tumor Suppressor PRDM5 Regulates Wnt Signaling at Early Stages of Zebrafish Development
Meani, N., Pezzimenti, F., Deflorian, G., Mione, M., & Alcalay, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004273 · Cited by 47
Metadata
- Authors
- Chadwick, R. B., Jiang, G.-L., Bennington, G. A., Yuan, B., Johnson, C. K., Stevens, M. W., Niemann, T. H., Peltomaki, P., Huang, S., & de la Chapelle, A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-02-25
- Volume
- 97
- Issue
- 6
- Pages
- 2662-2667
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2170069165
- Cited by
- 174
- References
- 2
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.